HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.

AbstractAIMS:
Seizure outcome of autoimmune encephalitis (AE) varies from seizure-free to refractory epilepsy, and the associated factors remain unclear. We aimed to describe seizure characteristics, identify seizure outcome-related factors, and discuss the medication strategy of antiepileptic drugs (AEDs) at the first onset of AE.
METHODS:
We retrospectively studied the data of 86 patients with clinically diagnosed AE. The clinical characteristics were described using a chi-square test. Seizure outcome-related factors were assessed using multivariable logistic regression analysis.
RESULTS:
56 patients were finally enrolled, with antibodies to N-methyl-D-aspartate receptor found in 29, to γ-aminobutyric acid receptor B found in 13, and to leucine-rich glioma-inactivated protein 1 found in 14. Status epilepticus occurrence and onset with seizure lead to a poor seizure outcome, while administration of human gamma globulin and a low antibody titer contributed to a good seizure outcome.
CONCLUSIONS:
In the acute phase, seizure characteristics may be considered in the utilization of AEDs. For patients with seizure-free status in the acute phase, clinical manifestation (onset with seizure or not, whether status epilepticus occurs or not), therapy regimen (human gamma globulin administered or not), and antibody titer may be considered when formulating the strategy for withdrawal of AEDs post-acute phase.
AuthorsYilin Wang, Xin Li, Pingping He, Jiangning Yin, Ruofei Dong, Yu Fu, Hong Zhang
JournalCNS neuroscience & therapeutics (CNS Neurosci Ther) Vol. 27 Issue 6 Pg. 694-701 (06 2021) ISSN: 1755-5949 [Electronic] England
PMID33683811 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.
Chemical References
  • Anticonvulsants
  • Receptors, GABA-A
  • Receptors, N-Methyl-D-Aspartate
  • gamma-Globulins
Topics
  • Adolescent
  • Adult
  • Anticonvulsants (therapeutic use)
  • Autoimmune Diseases (complications, drug therapy)
  • Child
  • Child, Preschool
  • Encephalitis (complications, drug therapy, immunology)
  • Female
  • Humans
  • Immunotherapy
  • Infant
  • Infant, Newborn
  • Male
  • Receptors, GABA-A (immunology)
  • Receptors, N-Methyl-D-Aspartate (immunology)
  • Retrospective Studies
  • Seizures (drug therapy, etiology)
  • Status Epilepticus
  • Treatment Outcome
  • gamma-Globulins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: